Andere talen Korro Bio, Inc.

Aandelen

KRRO

US5009461089

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
66,74 ^USD	-0,06%		-10,99%	+39,24%

28/03	KORRO BIO, INC. : HC Wainwright herhaalt koopadvies	ZM
27/03	KORRO BIO, INC. : RBC Capital Markets nog altijd een koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Korro Announces $70 Million Private Placement	18/04
Korro Bio, Inc. announced that it expects to receive $69.959848 million in funding from Atlas Venture L.P.	17/04
Korro to Participate in Upcoming Investor Conferences	01/04
Korro Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress	26/03
North American Morning Briefing : Stocks Struggle After New Records	22/03
North American Morning Briefing : Inflation -2-	15/03
Korro Bio: Development and Application of Graph Neural Networks to Design Guide Oligonucleotides that Promote RNA Editing	13/03
Korro to Present at the TD Cowen 44th Annual Health Care Conference	27/02
Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing Portfolio	18/01
Korro to Present at the 42nd Annual J.P. Morgan Healthcare Conference	04/01
Korro Announces Selection of Its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency	07/12
Korro Bio, Inc. Appoints Rachel Meyers as Board of Directors, Member of Nominating and Corporate Governance Committee	28/11
Frequency Therapeutics, Inc.(NasdaqCM:FREQ) dropped from NASDAQ Composite Index	03/11
Korro Bio, Inc. completed the acquisition of Frequency Therapeutics, Inc. from a group of shareholders.	03/11
Frequency Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02/11
FREQUENCY THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Frequency Therapeutics, Inc. - FREQ	06-10-23
Frequency Therapeutics : Termination of Material Agreement - Form 8-K	27-09-23
North American Morning Briefing : Stock Futures -2-	27-09-23
Frequency Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Korro Bio, Inc.

Aandelen

KRRO

US5009461089

Andere talen

Filters